abstract |
The present invention relates to a compound of formula (I) And further related compounds described herein and pharmaceutical compositions comprising these compounds. The invention further provides methods of using these compounds and compositions for the treatment of disorders associated with undesirable levels of Pim kinase activity, including cancer and autoimmune disorders. |